NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Retatrutide from Cellupep? Mail in a sample (US only) and let us test it.

Test my supply
+8 more ↓
77%
Finnrick rating
#218 of 419 Retatrutide vendors
14 of 18 classifiable tests passed
customers 4.7★ (19)
methodology · Purity focus
Finnrick analysis · Retatrutide

Cellupep Retatrutide is held down by volatility: most vials cleared the purity-focus bar, but failures include an identity fail and a recent 97.79% purity result. The key question is whether that late miss is an outlier or a trend.

methodology →
vendor intelligence report
Vendor Intelligence Report: Cellupep

Corporate and domain records point to a recent, privacy-protected operation behind Cellupep’s manufacturer-style claims. The full report follows the COA gallery, UK/HK contact layer, European storefront, and mixed fulfillment trail without relying on vendor screenshots.

26 pages6 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
84%
5
2
Tirzepatide
$0.48
79%
7
3
Retatrutideselected
$1.00
77%
18
4
Tesamorelin
$2.00
49%
4
5
BPC-157
$0.75
42%
6
6
TB-500
$1.26
41%
4
7
Glutathione
$0.01
-
0
8
HGH
$1.33
-
0
9
Ipamorelin
$1.10
-
0
10
KPV
$0.50
-
0
11
MOTS-c
$0.68
-
0
12
NAD+
$0.01
-
0
13
PT-141
$0.75
-
0
15
SS-31
$0.84
-
0
16
Wolverine
$0.85
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%17 Nov 2025: 75%17 Dec 2025: 77%7 Jan 2026: 79%26 Jan 2026: 82%26 Jan 2026: 78%18 Feb 2026: 79%18 Feb 2026: 80%22 Feb 2026: 81%22 Mar 2026: 83%25 Mar 2026: 84%28 Apr 2026: 80%11 May 2026: 81%11 May 2026: 82%13 Jul 2026: 83%3 Aug 2026: 83%9 Aug 2026: 80%14 Oct 2026: 80%27 Oct 2026: 77%15 Nov 2026: current 77%75%83%77%Nov 25Nov 26
Showing Retatrutide tests only
Peptide testing

Ordered Retatrutide from Cellupep? Mail in a sample (US only) and let us test it.

Test my supply
Cellupep Retatrutide test history
COA-backed lab tests
1-10 of 18

About Cellupep test results from Finnrick

Cellupep is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 44 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Cellupep peptides in this dataset are BPC-157 (6 tests), GHK-Cu (5 tests) and Retatrutide (18 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 44 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Retatrutide from Cellupep? Mail in a sample (US only) and let us test it.

Test my supply